Resveratrol as an Adjunct Therapy in Periodontal Disease: A Systematic Review and Meta-Analysis
Nutrients · 07.07.2026 · 18 (13) · 2212
DOI: 10.3390/nu18132212 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 07.07.2026. Verfasst von Suzanne Ying-Shan Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Xindian, New Taipei City 23142, Taiwan. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Antioxidants, Periodontal Diseases, Resveratrol. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Resveratrol, a natural polyphenol with anti-inflammatory and antioxidant properties, has emerged as a promising adjunctive agent in periodontal therapy. This systematic review and meta-analysis evaluated evidence from in vitro, in vivo, and human clinical studies regarding the effects of resveratrol on periodontal disease, with the clinical component focusing on systemically healthy non-smoking patients.
Methods
Electronic searches of MEDLINE/PubMed, Scopus, Embase, and Web of Science were conducted for studies published between 2000 and 2025. Eligible studies included periodontal-related in vitro cell models, in vivo experimental periodontitis models, and randomized clinical trials assessing resveratrol as an adjunctive therapy. Data extraction, risk-of-bias assessment, and meta-analyses were conducted in accordance with PRISMA guidelines.
Results
Fifteen studies were included (five in vitro, six in vivo, and five human randomized controlled trials). Meta-analysis showed the inhibitory effect of resveratrol on the lipopolysaccharide-induced protein expression of IL-1β, IL-6, TNF-α, and IL-8 in vitro, with low to moderate heterogeneity. In animal studies, resveratrol significantly attenuated ligature-induced dental alveolar bone loss, IL-1β protein, and relative mRNA expression. However, reductions in relative mRNA expressions of TNF-α and IL-6 were inconsistent and highly heterogeneous; in contrast, nanoparticle- and liposomal-modified resveratrol consistently and significantly reduced these mRNA levels. In human trials, adjunctive resveratrol was associated with improvements in probing pocket depth and clinical attachment level compared with root planing alone in patients with periodontitis, as well as reductions in bleeding and plaque indices in patients with periodontal diseases, including gingivitis and periodontitis.
Conclusions
Resveratrol suppresses pro-inflammatory cytokine expression in vitro and attenuates alveolar bone loss in vivo, with enhanced and more consistent molecular effects observed using modified formulations. Preliminary clinical evidence suggests that resveratrol may be associated with modest adjunctive effects on periodontal outcomes in systemically healthy non-smokers. However, given the limited number of clinical trials, small sample sizes, heterogeneity among studies, short follow-up periods, and limited certainty of the evidence, these findings should be interpreted cautiously. Further well-designed RCTs with longer follow-up periods are required to determine their clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Xindian, New Taipei City 23142, Taiwan.
- Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
- Department of Dentistry, School of Oral Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei 114202, Taiwan.
ORCID-Profile: Suzanne Ying-Shan Su, I-Shiang Tzeng, Earl Fu
Zitieren
APA
Su, S. Y., Tzeng, I. S., Huang, T. H., & Fu, E. (2026). Resveratrol as an Adjunct Therapy in Periodontal Disease: A Systematic Review and Meta-Analysis. Nutrients, 18(13), 2212. https://doi.org/10.3390/nu18132212
Vancouver
Su SY, Tzeng IS, Huang TH, Fu E. Resveratrol as an Adjunct Therapy in Periodontal Disease: A Systematic Review and Meta-Analysis. Nutrients. 2026;18(13):2212. doi:10.3390/nu18132212
BibTeX
@article{Su2026,
author = {Su, Suzanne Ying-Shan and Tzeng, I-Shiang and Huang, Ting-Hsin and Fu, Earl},
title = {Resveratrol as an Adjunct Therapy in Periodontal Disease: A Systematic Review and Meta-Analysis},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {13},
pages = {2212},
doi = {10.3390/nu18132212}
}
EUVIMED